1.19 +0.02 (1.69%)
CYTK
| Trade CYTK now with |
|
Stock Details
Last Trade:1.19 Change:+0.02 (1.69%) Prev Close:1.17 Open: 1.18 Days Range:1.17 – 1.22 52 Week Range: 0.89 - 1.92 Volume:360974 P/E: N/AEPS:-0.72
View AllRecent Alerts 02/09/12
Recent Alert on 02/03/12 at 9:53am
Canaccord Genuity Maintains a 'Buy' on Cytokinetics (CYTK); Focus on New CK357 ALS Phase 2 Data at AAN in April
Canaccord Genuity Maintains a 'Buy' on Cytokinetics (CYTK); Focus on New CK357 ALS Phase 2 Data at AAN in April
Canaccord Genuity maintains a 'Buy' on Cytokinetics (NASDAQ: CYTK) price target of $6.00. Analyst, Ritu Baral, said, "We see CYTK shares as inexpensive on potential of CK357 in ALS, AMGN- K357 in ALS, AMGN---partnered omecamtiv in heart failure.... Read More
Recent Alert on 02/02/12 at 4:13pm
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Recent Alert on 02/02/12 at 4:13pm
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Recent Alert on 02/01/12 at 5:54pm
Trading Radar for 02/02: MasterCard (MA), Dow Chemical (DOW), Wynn Resorts (WYNN), Viacom (VIA-B) Report
Trading Radar for 02/02: MasterCard (MA), Dow Chemical (DOW), Wynn Resorts (WYNN), Viacom (VIA-B) Report
View AllRecent Press Releases
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 07/20/11 at 3:47am
Cytokinetics' Promising Pipeline: Value Stock for a Long-Term Investor
Cytokinetics' Promising Pipeline: Value Stock for a Long-Term Investor
Blog Posts on 02/28/11 at 10:46am
22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12
22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12